Note: Ingredients listed on restricted chemical lists
EC/CAS
107534-96-3
Name of the chemical
1-(4-Chlorphenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol (2015/1221)
Concentration
N/A
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
N/A
General Information
Product name
Orius 45 DF Foliar Fungicide
Chemical name
Tebuconazole: α-(2-(4-Chlorophenyl)ethyl)-α-(1-1- dimethylethyl)-1H-1,2,4-triazole-1-ethanol
Manufacturer Name
Makhteshim Agan of North America, Inc
Icons in SDS
Company Information
company name
Makhteshim Agan of North America, Inc
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW WARNING Cause substantial but temporary eye injury. Harmful if swallowed, inhaled or absorbed through the skin. Prolonged or frequently repeated skin contact may cause allergic reactions in some individuals. Do not get in eyes, on skin, or on clothing. Avoid breathing dust or spray mist. PHYSICAL PROPERTIES Appearance: Tan granules Odor: Slight
Principle Routes of Exposure
Inhalation; skin contact; skin absorption; eye contact. IMMEDIATE EFFECTS : Eye: Cause substantial but temporary eye injury. Do not get in eyes. Skin: Harmful if absorbed through skin. May cause slight irritation. May cause sensitization by skin contact. Avoid contact with skin and clothing. Ingestion: Harmful if swallowed. Do not take internally. Inhalation: Harmful if inhaled. Avoid breathing dust or spray mist. CHRONIC OR DELAYED LONG-TERM : This product is not listed as a carcinogen by ACGIH, NTP, IARC or OSHA. However, it may contain crystalline silica (quartz), a substance which has been listed as a carcinogen by ACGIH, NTP and IARC. Crystalline silica is a naturally-occurring mineral component of many sands and clays. Although the carcinogenic potential of crystalline silica in humans is controversial, it must be considered if it is inhaled under excessive exposure conditions. The respirable portion of the silica that may be contained in this product, however, is small, such that excessive inhalation exposure during anticipated conditions of use is unlikely.
Medical Conditions Generally Aggravated by Exposure
No specific medical conditions are known which may be aggravated by exposure to this product. As with all materials which can cause upper respiratory tract irritation, persons with a history of asthma, emphysema, or hyperactive airways disease may be more susceptible to overexposure. Pulmonary and respiratory diseases may be aggravated by exposure to respirable crystalline silica. HAZARDOUS DECOMPOSITION PRODUCTS : Thermal decomposition, CO, CO2 and NOx UNUSUAL FIRE/EXPLOSION HAZARDS Dust Explosion Hazard Specific testing with tebuconazole is not complete. Tests indicate low ignition energy for dust cloud, meaning that an explosive mixture can develop. Measures should be taken to eliminate buildup of static charge during routine material handling. All equipment should be grounded and material stored in containers lined with conductive plastic bags. If large dust cloud develops, turn off all devices that may cause spark and leave area until cloud dissipates.